HDAC9 and chondrosarcoma: In this study, we found that chondrosarcoma cell lines are highly sensitive to HDAC inhibition in both 2D and 3D in vitro models, especially to pan-HDAC inhibitors and the specific class I HDAC inhibitor romidepsin.